Diseases Associated With Negative Regulation Of Plasminogen Activation
Disease |
Obesity
|
Amenorrhea
|
Anti-Plasmin Deficiency, Congenital
|
Arthritis, Juvenile
|
Atherosclerosis
|
Autism
|
Azotemia
|
Behcet's Syndrome
|
Breast Carcinoma
|
Cardiovascular Disease
|
Cholestasis
|
Diabetes Mellitus, Experimental
|
Diabetic Angiopathies
|
Diabetic Nephropathy
|
Diabetic Retinopathy
|
Disease Models, Animal
|
Fatty Liver
|
Fibrosis
|
Focal Segmental Glomerulosclerosis
|
Growth Disorders
|
Growth Hormone-Secreting Pituitary Adenoma
|
Heart Failure
|
Hypertension
|
Insulin Resistance
|
Isolated Growth Hormone Deficiency, Type Ib
|
Isolated Growth Hormone Deficiency, Type Ii
|
Kidney Failure, Chronic
|
Kowarski Syndrome
|
Liver Cirrhosis
|
Liver Cirrhosis, Experimental
|
Liver Neoplasms
|
Mammary Neoplasms, Experimental
|
Muscular Atrophy
|
Nephritis, Interstitial
|
Nephrotic Syndrome
|
Nervous System Diseases
|
Pituitary Dwarfism 1
|
Pituitary Neoplasms
|
Plasminogen Activator Inhibitor-1 Deficiency
|
Polycythemia
|
Preeclampsia
|
Prostatic Neoplasms
|
Reperfusion Injury
|
Respiratory Hypersensitivity
|
Schizophrenia
|
Short Stature, Idiopathic, Autosomal
|
Stomach Neoplasms
|
Thrombosis
|
Turner Syndrome
|
Acromegaly
|
Weight Gain
|